autologous Tcm cellular immunotherapy
/ Newish Technology
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
May 24, 2023
Clinical Trial of Autologous Tcm Immunotherapy in ICC
(clinicaltrials.gov)
- P2 | N=20 | Recruiting | Sponsor: Newish Technology (Beijing) Co., Ltd. | Trial completion date: Dec 2023 ➔ Dec 2025 | Trial primary completion date: Jun 2023 ➔ Jun 2025
Trial completion date • Trial primary completion date • Biliary Cancer • Cholangiocarcinoma • Gastrointestinal Cancer • Oncology • Solid Tumor
April 26, 2022
Clinical Trial of Autologous Tcm Immunotherapy in ICC
(clinicaltrials.gov)
- P2 | N=20 | Recruiting | Sponsor: Newish Technology (Beijing) Co., Ltd. | Trial completion date: Apr 2022 ➔ Dec 2023 | Trial primary completion date: Apr 2021 ➔ Jun 2023
Trial completion date • Trial primary completion date • Biliary Cancer • Cholangiocarcinoma • Gastrointestinal Cancer • Oncology • Solid Tumor
1 to 2
Of
2
Go to page
1